Enzolytics Inc (ENZC)

[foxi]

Noted, regarding the important minor details. And yes there's a big difference between an ENZC application and a Rosetta Lifecare BG application for EnzoImmune Active...


Did some more digging:

This dietary supplement is being distributed by Rosetta Lifecare Bulgaria and some investors seem convinced that EnzoImmune Active is a product of Enzolytics.

However, I couldn’t confirm this and Enzolytics didn’t report any revenues in the first nine months of 2020.

https://seekingalpha.com/article/4413985-enzolytics-surrounded-by-controversy-potentially-worthless

The authors conjured up a point that Enzoimmune Active, a supplement sold as a ‘dietary supplement’ is being distributed by Rosetta Lifecare Bulgaria. As innocuous as that sounds, some investors seem convinced that EnzoImmune Active is a product of Enzolytics. The author then points out that no revenue was observed in the company’s SEC filings, and therefore the supplement couldn’t be associated with the company.

While the supplement doesn’t seem to be associated with the company, it seems possible that the drug is marketed as a supplement and not a drug, for now. The question of why there is no revenue is a good question, but the supplement is clearly associated with the ITV-1, as the website references a patent owned by Harry Zabiliov, Enzolytics’ Chief Scientific Officer

https://insiderfinancial.com/enzolytics-enzc-working-with-intel-intc/181517/

An ENZC Immunomodulator will be available soon in the US market.

An ENZC Immunomodulator will be available soon in the US market.

— Gaurav Chandra M.D. (@drgauravchandra) November 3, 2021

So are we discussing potayto vs potahto since Harry works for ENZC and Harry's family trust owns the IPF (ITV-1) patent? Or is ENZC currently not (known to be) affiliated with Rosetta Lifecare BG's EnzoImmune trademark and product?

I looked through some of the OTC filings for ENZC and there's no mention of Rosetta Lifecare BG in any of the recent ones. There's a mention of "Bulgarian Partners" in regards to IMBL on page 12 of https://www.otcmarkets.com/otcapi/company/financial-report/300160/content